Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-10-04 00:00:00 ET · period of report 2022-09-30 · accession 0001562180-22-007012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-04 | 2022-09-30+ | SNDX | Metzger Michael A | CEO, Dir | M - OptEx | $8.77 | +33.8K | 20.5K | New | +$296.2K |
| DM | 2022-10-04 | 2022-09-30+ | SNDX | Metzger Michael A | CEO, Dir | S - Sale+OE | $25.02 | -33.8K | 17.7K | -66% | -$844.9K |
| DM | 2022-10-04 | 2022-09-30+ | SNDX | Metzger Michael A | CEO, Dir | M - OptEx | $0.00 | -33.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-04 | M | A | 1,280 | $8.77 | 18,939 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-04 | S | D | 1,280 | $25.02 | 17,659 | D | — | — | (F3) The sale prices ranged from $25.00 to $25.03. |
| 3 | Common | Common Stock | 2022-10-03 | S | D | 2,883 | $25.01 | 17,659 | D | — | — | (F3) The sale prices ranged from $25.00 to $25.03. |
| 4 | Common | Common Stock | 2022-09-30 | S | D | 29,606 | $25.02 | 17,659 | D | — | — | (F2) The sale prices ranged from $25.00 to $25.15. |
| 5 | Common | Common Stock | 2022-09-30 | M | A | 29,606 | $8.77 | 47,265 | D | — | — | |
| 6 | Common | Common Stock | 2022-10-03 | M | A | 2,883 | $8.77 | 20,542 | D | — | — | |
| 7 | Derivative | Stock Options (Right to buy) | 2022-09-30 | M | D | 29,606 | $0.00 | 0 | D | $8.77 · — to 2027-02-06 | 29,606 Common Stock | (F4) This option is fully vested. |
| 8 | Derivative | Stock Options (Right to buy) | 2022-10-04 | M | D | 1,280 | $0.00 | 0 | D | $8.77 · — to 2027-02-06 | 1,280 Common Stock | (F4) This option is fully vested. |
| 9 | Derivative | Stock Options (Right to buy) | 2022-10-03 | M | D | 2,883 | $0.00 | 0 | D | $8.77 · — to 2027-02-06 | 2,883 Common Stock | (F4) This option is fully vested. |